secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2022-11-28T23:59:59+00:00
Accession:  0001437749-22-028094
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma stockholders re-elect Eric Friedman as Class III director, ratify Marcum LLP as auditor
--------------------------------------------------------------------------------

- Eric Friedman elected as Class III director for term until 2025 Annual Meeting; vote: 21.7M for, 85.9K withheld, 1.6M broker non-votes.
- Ratification of Marcum LLP as independent auditor for FY ending June 30, 2023 approved: 23.4M for, 25.8K against, 30K abstain.
- Quorum of 23.5M shares out of 29.9M outstanding shares present at November 28, 2022 Annual Meeting.
- No other matters were voted upon at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774922028094/0001437749-22-028094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774922028094/inbp20221128_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer